|
|
- Care Trusts
- Mental Health Trusts
- MHRA (Medicines) Drug Alerts (Various Recipients)
- Other contacts
- Specialists Trusts
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- NHS Regional Offices
- Learning Disabilities Trusts
- Mental Health & Social Care Trusts
- NHS Foundation Trusts (England) - Medical Director
- NHS Foundation Trusts (England) - Chief Executive
- Ofsted recipients
- Ambulance Trusts
- Social Care Providers (registered with CAS)
- Special Health Authorities
- NHS Trusts (England) - Medical Director
- CMO Urgent Messages - Non-NHS Recipients on Public Health Link
- MHRA (Medicines) Drug Alerts - Non-NHS Recipients
- Mental Health & Learning Disabilities Trusts
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
- Consultants in Communicable Diseases
- CMO Urgent Messages - Recipients on Public Health Link
- Director of Public Health
- Acute Trusts
- Community Trusts
- NHS Trusts (England) - Chief Executive
- GP - Locum
- NHS 111 and Out of hours providers
- Dispensing GP Practices
- GP Practices
- DHSC Supply Disruption - Medicines
- Out of hours contacts
- Community Pharmacy
- Primary Care Networks
- GP Practices 1
|
| Title: |
|
Changes to MHRA Drug Alert titles and classifications
|
| Broadcast content: |
|
The attached provides
further information regarding MHRA Defective Medicines Report Centre safety
messaging. This replaces CH/2021/001 which was published on 02
February 2021.
|
| Additional information: |
|
NHS England and NHS Improvement Regional Offices: please cascade this message to Community Pharmacy, Dental and Optometry contractors.
|